Willow Biosciences (TSE:WLLW) Shares Down 12.5% – Here’s Why

Willow Biosciences Inc. (TSE:WLLWGet Free Report) traded down 12.5% during mid-day trading on Friday . The stock traded as low as C$0.03 and last traded at C$0.04. 483,168 shares were traded during trading, a decline of 29% from the average session volume of 676,576 shares. The stock had previously closed at C$0.04.

Willow Biosciences Trading Down 12.5 %

The company has a debt-to-equity ratio of 902.05, a quick ratio of 19.71 and a current ratio of 0.80. The firm has a market cap of C$5.07 million, a price-to-earnings ratio of -0.64 and a beta of 1.13. The company’s 50-day moving average is C$0.02 and its 200-day moving average is C$0.05.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Featured Articles

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.